ϩ CD25 high regulatory T (Treg) cells have been shown to be involved in the pathogenesis of autoimmune diseases. Vogt-Koyanagi-Harada (VKH) syndrome is an organspecific autoimmune disease. This study was designed to phenotypically and functionally characterize peripheral blood CD4 ϩ CD25 high Treg cells in VKH patients with active uveitis. Winged-helix/forkhead transcription factor foxp3 (FOXP3) has been a reliable marker for CD4 ϩ CD25 ϩ Treg cells and is critical for maintaining immune tolerance and preventing autoimmune diseases. 5, 6 Convincing evidence has established that certain mutations in the FOXP3 gene in humans leads to the IPEX syndrome (immunodysregulation, polyendocrinopathy, and enteropathy X-linked syndrome).
METHODS. Blood samples were taken from 30 patients with active VKH, 19 patients with inactive VKH, and 26 healthy controls. Peripheral blood mononuclear cells were subjected to flow cytometry for analysis of phenotypes of the CD4 I nitially, CD4 ϩ CD25 ϩ regulatory T (Treg) cells were identified in the mouse and were characterized by their immunoregulatory ability to inhibit the development of certain autoimmune diseases in animal models. 1, 2 It has been reported that approximately 5% to 10% of the human CD4 ϩ T-cell subpopulation from peripheral blood expresses CD25 (IL-2 receptor ␣ chain) and that of these cells only 1% to 2% express high levels of CD25. These CD4 ϩ CD25 high cells have regulatory properties and are designated CD4 ϩ CD25 high regulatory T (Treg) cells. 3, 4 Winged-helix/forkhead transcription factor foxp3 (FOXP3) has been a reliable marker for CD4 ϩ CD25 ϩ Treg cells and is critical for maintaining immune tolerance and preventing autoimmune diseases. 5, 6 Convincing evidence has established that certain mutations in the FOXP3 gene in humans leads to the IPEX syndrome (immunodysregulation, polyendocrinopathy, and enteropathy X-linked syndrome). 7 Apart from FOXP3, human glucocorticoid-induced tumor necrosis factor receptor (GITR), intracellular cytotoxic T lymphocyte antigen (CTLA)-4, and CD45RO are potential markers for identifying CD4 high Treg cells has been reported in patients with a number of autoimmune diseases, including multiple sclerosis, psoriasis, systemic lupus erythematosus, and rheumatoid arthritis. 8 -11 Vogt-KoyanagiHarada (VKH) syndrome is an organ-specific autoimmune disease characterized by chronic bilateral granulomatous panuveitis and involvement of the central nervous, auditory, and integumentary systems. 12, 13 Whether an altered frequency and impaired function of CD4 ϩ CD25 high Treg cells is possibly associated with the pathogenesis of VKH syndrome must be addressed and was, therefore, the subject of the study described here. 
CD25
high Treg cells are associated with the active uveitis seen in VKH patients.
MATERIALS AND METHODS

Patients
Forty-nine VKH patients were referred to the uveitis study center of Sun Yat-sen University were included in this study. The diagnosis of VKH syndrome was made according to the diagnostic criteria revised for VKH syndrome by an international committee on nomenclature.
14 Thirty VKH patients (18 males, 12 females; age range, 24 -52 years) had active uveitis, as evidenced by mutton fat keratic precipitates, cells in the anterior chamber and vitreous body in association with sunset glow fundus, and Dalen-Fuchs nodules. The systemic findings included headache (6 patients), scalp supersensitivity of skin (16 patients), tinnitus (8 patients), dysacusis (7 patients), poliosis (11 patients), alopecia (9 patients), and vitiligo (9 patients). These patients did not use immunosuppressive agents at least for 1 week or used only a low dosage of corticosteroids (Ͻ20 mg/day) before blood sampling. Nineteen VKH patients (13 males, 6 females; age range, 23-55 years) had no active intraocular inflammation. No suppressive agent was used at least for 1 month before blood sampling. Twenty-six healthy persons (17 males, 9 females; age range, 20 -55 years) served as controls. All procedures followed the tenets of the Declaration of Helsinki.
Flow Cytometry
Peripheral blood mononuclear cells (PBMCs) were isolated from freshly drawn heparinized blood by Ficoll-Hypaque gradient centrifugation and were stained by direct immunofluorescence using fourcolor flow cytometry (FCM; FACSAire; BD Biosciences, Franklin Lakes, NJ). To analyze cell surface molecule expression, the PBMCs were incubated with the appropriate monoclonal antibodies (mAbs), followed by fixation in 4% paraformaldehyde. Alternatively, cells were permeabilized and fixed using fixation/permeabilization solution (eBioscience, San Diego, CA) and were stained with the appropriate mAbs for examination of the expression of intracellular molecules. The mAbs used in this study were FITC-anti-CD3, PEcy7-anti-CD4, PE-anti-CD25, PE-anti-CTLA-4, antigen-presenting cell (APC)-anti-FOXP3 staining set, APC-anti-GITR, FITC-anti-CD69 and APC-anti-CD45RO (purchased from eBioscience, San Diego, CA), APC-anti-CD3, FITC-anti-CD4, and PEcy5-anti-CD25 (purchased from Beckman Coulter, Fullerton, CA). 
Cell Purification
ELISA
To analyze cytokine production, 100 L supernatant was removed from cultures of proliferation and additional comixing experiments stimulated with immobilized anti-CD3 mAb. Levels of IL-17, IFN-␥, and IL-13 were measured using human ELISA development kits (Duoset; R&D Systems, Minneapolis, MN) with detection limits of 15 pg/mL, 15 pg/mL, and 90 pg/mL, respectively.
Statistical Analysis
Data are expressed as mean Ϯ SD. Statistical analysis was performed using Student's t-test. P Ͻ 0.05 was considered statistically significant.
RESULTS
Decreased Frequency of CD4
؉
CD25
high Treg Cells in Active VKH Our data showed a significantly decreased percentage of CD4 ϩ CD25 high Treg cells in patients with active VKH compared with healthy controls (P ϭ 0.002) and patients with inactive VKH (P ϭ 0.010; Figs. 1A, 1B). Furthermore, the intensity of CD25 expression of CD4 ϩ T cells indicated by mean fluorescence intensity was also decreased in patients with active VKH (Fig. 1C) . The frequency of the total CD4 ϩ CD25 ϩ T-cell population was not altered in patients with active VKH (Fig. 1B) .
Decreased Expression of FOXP3 in Active VKH Patients
The results of our further experiments showed that FOXP3 was expressed by most (82%-95%) CD4
ϩ CD25 high Treg cells in VKH patients and healthy controls. A significantly decreased frequency of Foxp3 ϩ cells in CD4 ϩ CD25 high Treg cells was detected in patients with active VKH compared with healthy controls (P ϭ 0.001) and patients with inactive VKH (P ϭ 0.023; Fig. 2A 
CD25
Ϫ T-cell proliferation by an average of 35.9% that was significantly decreased compared with healthy controls (P Ͻ 0. 001) and patients with inactive VKH (P ϭ 0.001; Fig. 3C ).
Comixing experiments were performed simultaneously to further validate the diminished alloantigen-specific regulatory activity of the CD4 ϩ CD25 high Treg cells in patients with active VKH. The inhibitory effect of CD4 ϩ CD25 high Treg cells from patients with active VKH showed a significantly deficient effect on the proliferation of allogeneic CD4 ϩ CD25 Ϫ T cells (P ϭ 0.019, P ϭ 0.003, respectively; Fig. 3D ).
Subsequently ϩ CD25 Ϫ T cells by 36%, which was equal to that observed at ratios of 1:16 to 1:8 in patients with inactive VKH and in healthy controls (Fig. 3F ).
Inefficient Inhibition of CD4
؉
CD25
high Treg Cells from Active VKH Patients in the Production of IFN-␥ and IL-13 by Allogeneic CD4 ؉ CD25 ؊ T Cells
Supernatants from immobilized anti-CD3 mAb-stimulating cultures of CD4 ϩ CD25 Ϫ T cells in the presence of autologous APCs and allogeneic CD4 ϩ CD25 high Treg cells were removed to detect levels of IFN-␥ and IL-13. Results showed that the IFN-␥ level was significantly higher in patients with active VKH than in healthy controls (P Ͻ 0.001) and patients with inactive VKH (P ϭ 0.001). The production of IFN-␥ was significantly reduced in the presence of CD4 ϩ CD25 high Treg cells in patients with active VKH (P ϭ 0.002), healthy controls (P Ͻ 0.001), and patients with inactive VKH (P Ͻ 0.001). However, IFN-␥ levels in the coculture supernatants were significantly higher in patients with active VKH than in healthy controls (P Ͻ 0.001) and patients with inactive VKH (P Ͻ 0.001). These results showed that CD4 ϩ CD25 high Treg cells from patients with active VKH had less efficient suppression in IFN-␥ production (Fig. 4A) . Although IL-13 levels in CD4 ϩ CD25 Ϫ T cells culture supernatants were not different between VKH patients and healthy controls, a significantly increased level was noted in the coculture supernatants from patients with active VKH compared with healthy controls (P ϭ 0.018) and patients with inactive VKH (P ϭ 0.044; Fig. 4B ). Together with the results of comixing tests, a reduced ability of CD4 ϩ CD25 high Treg cells in suppressing the production of IFN-␥ and IL-13 was observed in patients with active VKH (Figs. 4C, 4D ). 
IOVS,
our data in VKH syndrome are the first to show this phenomenon in an autoimmune ocular disease. Our results revealed a decreased frequency of CD4 ϩ -CD25
high Treg cells that correlated with active uveitis in VKH patients. In addition, we found a decreased expression of CD25 (IL-2 receptor ␣ chain) on CD4 ϩ CD25 high Treg cells at the single-cell level. Recent studies have shown that signaling through the high-affinity IL-2 receptor is critical for the differentiation, survival, and function of CD4 ϩ CD25 high Treg cells. 18, 19 It is, therefore, presumed that the decreased expression of IL-2 receptor ␣ chain on CD4 ϩ CD25 high Treg cells may be one of the reasons for poor expansion and, in turn, may explain the lower frequency of CD4 ϩ CD25 high Treg cells in patients with active VKH.
Expression of the transcription factor FOXP3 has been implicated as a key element for murine CD4 
Treg cells on the production of IFN-␥ and IL-13 by cocultured allogeneic CD4 ϩ CD25 Ϫ T cells on the stimulation of anti-CD3 at a concentration of 5 g/mL (similar to the experiments shown in Figs. 3D and 3E) . Levels of IFN-␥ and IL-13 from culture supernatants were determined by ELISA. All data were expressed as mean Ϯ SD. (A, B) ϩ CD25 Ϫ T cells through the modulation of cytokines, we investigated the production of cytokines, including IFN-␥, IL-13, an important cytokine of Th2 cells, and IL-17, and the influence of the CD4 ϩ CD25 high Treg cells on the in vitro production of these cytokines. The results showed significantly increased IFN-␥ and IL-17 production in patients with active VKH, suggesting the involvement of both Th1 and Th17 cells in this disease. CD4 ϩ CD25 high Treg cells were able to significantly inhibit the production of IFN-␥. Importantly, CD4 ϩ CD25 high Treg cells from patients with active VKH exerted a far less inhibitory effect. We did not find an inhibitory effect of CD4 ϩ CD25 high Treg cells in patients or healthy controls in the production of IL-17 by allogeneic CD4 ϩ CD25 Ϫ T cells. This result is consistent with that presented recently by another group, 23 who found that the proliferation of a Th17 clone in response to allogeneic stimulation exhibited a significantly lower susceptibility to the suppressive activity of an autologous CD4 ϩ CD25 ϩ FOXP3 ϩ Treg cell clone. Taken together, the results demonstrated that CD4 ϩ CD25
high Treg cells in patients with active VKH were dysfunctional in inhibiting the production of IFN-␥ but not IL-17. Therefore, these dysfunctional Treg cells disclosed by proliferation experiments may be involved in the pathogenesis of VKH syndrome because of their inefficient suppressive effects on cytokine production.
A recent study has shown that FOXP3 is transiently expressed in polyclonally stimulated human CD4 ϩ CD25 Ϫ T cells and that these activated cells do not have a suppressive function in vitro. 24 Although our study did not exclude the possibility that a slight contamination of activated CD4 ϩ CD25 ϩ T cells may exist and a minor influence of low-dose corticosteroids was present, our results concerning the frequency and function of CD4 ϩ CD25 high Treg cells in VKH syndrome are generally consistent with those observed in other autoimmune diseases. 9 -12 Functionally diminished CD4 ϩ CD25 high Treg cells are found in these studies, though there are differences between the studies concerning the reported frequency of these Treg cells. It is likely that functional impairment of the CD4 ϩ CD25 high Treg subpopulation is one of the common final pathways involved in these autoimmune diseases, though the initial factors and insulting autoantigens may be different.
In conclusion, our study revealed significantly decreased frequency and diminished function of CD4 ϩ CD25 high Treg cells in patients with active VKH. These findings suggest that quantitatively abnormal and functionally diminished CD4 ϩ CD25 high Treg cells may be important for the development of active intraocular inflammation in VKH syndrome.
